<!--
✒ Metadata
    - Title: Aging and Longevity Works Cited (Knowledge Nexus 2026 Edition - v1.0)
    - File Name: aging_and_longevity_works_cited.md
    - Relative Path: articles\04-life-sciences\aging-and-longevity\aging_and_longevity_works_cited.md
    - Artifact Type: docs
    - Version: 1.0.0
    - Date: 2026-01-03
    - Update: Friday, January 03, 2026
    - Author: Dennis 'dnoice' Smaltz
    - A.I. Acknowledgement: Google Deep Mind - Gemini 3 Pro
    - Signature: ︻デ═─── ✦ ✦ ✦ | Aim Twice, Shoot Once!

✒ Description:
    Comprehensive bibliography matrix documenting all sources referenced in the
    Aging and Longevity deep-dive article. Organized by topic category with full
    citation information, publication dates, and access details.

✒ Key Features:
    - Feature 1: Categorized source organization by intervention type
    - Feature 2: Publication date tracking for currency verification
    - Feature 3: Direct URLs for source verification
    - Feature 4: Source type classification (academic, clinical, news)
    - Feature 5: Key data points extracted from each source

✒ Usage Instructions:
    Cross-reference with aging_and_longevity.md for fact verification.
    URLs current as of research date; verify accessibility before citation.
    Primary sources prioritized where available.

✒ Other Important Information:
    - Dependencies: Companion to aging_and_longevity.md
    - Research date: January 2026
    - Source verification: All sources accessed via web search
---------
-->

# Aging and Longevity: Works Cited

## Cellular Senescence and Senolytics

### Senolytic Research

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Toward precision longevity: aging interventions in the single-cell atlas era | Frontiers in Aging | Precision longevity approaches, single-cell targeting | 2025 |
| Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics | PMC | Comprehensive senolytic review | 2025 |
| Senescent cells as a target for anti-aging interventions | PMC | From senolytics to immune therapies | 2025 |
| The New Frontier In Longevity Science: Senolytics And Age-Reversal Therapies | GlobalRPH | Overview of therapeutic landscape | Dec 2025 |
| Targeting Senescence: A Review of Senolytics and Senomorphics | PMC | Anti-aging intervention review | 2025 |
| Targeting Cellular Senescence for Healthy Aging | Dove Press (DDDT) | Senolytic and senomorphic advances | 2025 |

### Clinical Trial Updates

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| New Harvard-Mayo-Cedars-Sinai Study Confirms Safety of Anti-Aging Senolytic Treatment | NMN.com | D+Q safe in Alzheimer's risk patients | 2025 |
| Insights into targeting cellular senescence with senolytic therapy | PubMed | From preclinical to clinical practice | Feb 2024 |
| dsm-firmenich launches three-step pack to tackle cellular senescence | Nutraingredients | Industry application of senescence science | Jul 2025 |
| Senolytics and the longevity of healthy humans | Springer Nature Communities | Human longevity implications | 2025 |

### Mechanism Studies

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Functional Features of Senescent Cells and Implications for Therapy | MDPI IJMS | 30-70% of senescent cells tissue-destructive | 2025 |
| Targeting Cell Senescence and Senolytics | Endocrine Reviews | Novel interventions for endocrine dysfunction | 2024 |
| The interplay of cellular senescence and reprogramming | Frontiers in Cell and Developmental Biology | Aging and cancer therapeutic avenues | 2025 |
| Reprogramming cellular senescence and aging clocks for cancer immunotherapy | PMC | Advanced immunotherapy applications | 2025 |

## Rapamycin and mTOR Inhibition

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Rapamycin for longevity: the pros, the cons, and future perspectives | Frontiers in Aging / PMC | Comprehensive pros/cons analysis | 2025 |
| Rapamycin, Not Metformin, Mirrors Dietary Restriction-Driven Lifespan Extension | Aging Cell (Wiley) | Meta-analysis of 911 comparisons | 2025 |
| Rapamycin Shows Limited Evidence for Longevity Benefits in Healthy Adults | Aging-US | Clinical evidence assessment | Aug 2025 |
| What is the clinical evidence to support off-label rapamycin therapy? | Aging-US | Evidence review | 2025 |
| PEARL Trial (NCT04488601) | ClinicalTrials.gov | Low-dose rapamycin trial design | 2020 |
| Anti-Aging Drug Rapamycin Extends Life as Much as Dieting | NAD.com | Meta-analysis coverage | 2025 |

## Metformin and TAME Trial

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| TAME - Targeting Aging with Metformin | American Federation for Aging Research | Trial design and FDA indication goal | Ongoing |
| NCT02432287 Metformin in Longevity Study (MILES) | ClinicalTrials.gov | Clinical trial record | 2015 |
| Rapamycin for longevity: opinion article | PMC | Comparison with metformin | 2019 |

## Epigenetic Clocks and Biomarkers

### Clock Development and Theory

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Epigenetic Clocks: Beyond Biological Age | Aging and Disease / PMC | Using past to predict present and future | 2024 |
| Probing epigenetic clocks as rational markers of biological age | medRxiv | Blood cell count relationship | 2025 |
| Epigenetic Regulation of Aging and its Rejuvenation | MedComm (Wiley) | Rejuvenation strategies | 2025 |
| Turning back the epigenetic clock: Can we reverse ageing? | Drug Discovery World | Reversal possibilities | Nov 2025 |
| Quantification of Epigenetic Aging in Public Health | Annual Reviews | Public health applications | 2025 |
| An epigenetic biomarker of aging for lifespan and healthspan | PMC | GrimAge development | 2018 |

### Clinical Applications

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Do we actually need aging clocks? | npj Aging (Nature) | Critical examination of practical value | 2025 |
| 2025 Biomarkers of Aging Conference | Biomarkers of Aging Consortium | Geroscience conference | 2025 |
| Epigenetic Age Acceleration and Cardiometabolic Biomarkers | PubMed | Weight-loss intervention effects | 2025 |
| DunedinPACE associations with cardiometabolic biomarkers | GeroScience | Insulin, cholesterol, CRP correlations | 2025 |

## NAD+ and Precursor Supplementation

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Use of Dietary Supplements NR and NMN | MDPI | NAD+ increase and mitochondrial function | 2025 |
| The Science Behind NMN–A Stable, Reliable NAD+ Activator | PMC | NMN mechanism review | 2020 |
| The Safety and Antiaging Effects of NMN in Human Clinical Trials | ScienceDirect | Update on human trials | 2023 |
| NMN and NR Pre-Clinical and Clinical Comparisons | Food Frontiers (Wiley) | Updated 2025 review | 2025 |
| Dietary Supplementation With NAD+-Boosting Compounds | PMC | Future directions | 2023 |
| Efficacy of oral NMN supplementation on glucose and lipid metabolism | Taylor & Francis | Systematic review with meta-analysis | 2024 |
| NMN and Personalised Longevity | Ezra | Hype vs future analysis | 2025 |
| A Current List of Completed NMN Human Trials | Renue By Science | Trial database | 2025 |
| NMN Safety and Efficacy in Middle-Aged Adults | GeroScience | 80 participants, dose-dependent | 2022 |

## Telomere Biology

### Telomere Research

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Exercise delays aging: evidence from telomeres and telomerase | Frontiers in Physiology | Systematic review and meta-analysis | 2025 |
| Telomere Attrition in Cancer and Aging | PMC | Molecular insights and therapeutic approaches | 2025 |
| Premature aging and metabolic diseases: the impact of telomere attrition | Frontiers in Aging | Metabolic disease connection | 2025 |
| The relationship between telomere length and aging-related diseases | PMC | Disease correlations | 2025 |
| Unlocking longevity: the role of telomeres and targeting interventions | PMC | Intervention strategies | 2024 |

### Telomerase Activation

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| TA-65MD: The Complete Guide to Telomerase Activation (2025 Update) | PureClean Performance | Cycloastragenol review | 2025 |
| Discovery of potent telomerase activators | PMC | Novel compound development | 2019 |
| Epitalon telomere extension in mammalian cells | Biogerontology (Springer) | hTERT upregulation, dose-dependent | 2025 |
| Telomere function and regulation from mouse models | PMC | Mouse to human translation | 2025 |
| Telomerase and the aging process | PMC | Foundational review | 2007 |

## Reference URLs

### Senolytics

- <https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2025.1674112/full>
- <https://pmc.ncbi.nlm.nih.gov/articles/PMC12456441/>
- <https://pmc.ncbi.nlm.nih.gov/articles/PMC11921816/>
- <https://globalrph.com/2025/12/the-new-frontier-in-longevity-science-senolytics-and-age-reversal-therapies/>
- <https://www.nmn.com/news/new-harvard-study-anti-aging-senolytics-are-safe-for-seniors-with-memory-loss>

### Rapamycin

- <https://pmc.ncbi.nlm.nih.gov/articles/PMC12226543/>
- <https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2025.1628187/full>
- <https://onlinelibrary.wiley.com/doi/10.1111/acel.70131>
- <https://www.aging-us.com/news-room/rapamycin-shows-limited-evidence-for-longevity-benefits-in-healthy-adults>
- <https://clinicaltrials.gov/study/NCT04488601>

### Metformin and TAME

- <https://www.afar.org/tame-trial>
- <https://clinicaltrials.gov/study/NCT02432287>

### Epigenetic Clocks

- <https://pmc.ncbi.nlm.nih.gov/articles/PMC12539533/>
- <https://www.aginganddisease.org/EN/10.14336/AD.2024.1495>
- <https://www.medrxiv.org/content/10.1101/2025.05.12.25327213v1.full>
- <https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.70369>
- <https://www.ddw-online.com/turning-back-the-epigenetic-clock-can-we-reverse-ageing-38601-202511/>
- <https://www.nature.com/articles/s41514-025-00312-2>

### NAD+ Research

- <https://www.mdpi.com/3042-5158/1/2/9>
- <https://pmc.ncbi.nlm.nih.gov/articles/PMC7238909/>
- <https://www.sciencedirect.com/science/article/pii/S2161831323013595>
- <https://iadns.onlinelibrary.wiley.com/doi/10.1002/fft2.511>
- <https://www.tandfonline.com/doi/full/10.1080/10408398.2024.2387324>
- <https://link.springer.com/article/10.1007/s11357-022-00705-1>

### Telomeres

- <https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2025.1627292/full>
- <https://pmc.ncbi.nlm.nih.gov/articles/PMC11764024/>
- <https://pmc.ncbi.nlm.nih.gov/articles/PMC11882723/>
- <https://pmc.ncbi.nlm.nih.gov/articles/PMC10850353/>
- <https://purecleanperformance.com/blogs/coaches-corner/ta-65-the-complete-guide-to-telomerase-activation-2025-update>

---

> **︻デ═─── ✦ ✦ ✦ | Aim Twice, Shoot Once!**
